{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:26:18Z","timestamp":1794871578623,"version":"4.9.1"},"reference-count":106,"publisher":"Cambridge University Press (CUP)","issue":"16","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Psychotropic medication efficacy and tolerability are critical treatment issues faced by individuals with psychiatric disorders and their healthcare providers. For some people, it can take months to years of a trial-and-error process to identify a medication with the ideal efficacy and tolerability profile. Current strategies (e.g. clinical practice guidelines, treatment algorithms) for addressing this issue can be useful at the population level, but often fall short at the individual level. This is, in part, attributed to interindividual variation in genes that are involved in pharmacokinetic (i.e. absorption, distribution, metabolism, elimination) and pharmacodynamic (e.g. receptors, signaling pathways) processes that in large part, determine whether a medication will be efficacious or tolerable. A precision prescribing strategy know as pharmacogenomics (PGx) assesses these genomic variations, and uses it to inform selection and dosing of certain psychotropic medications. In this review, we describe the path that led to the emergence of PGx in psychiatry, the current evidence base and implementation status of PGx in the psychiatric clinic, and finally, the future growth potential of precision psychiatry via the convergence of the PGx-guided strategy with emerging technologies and approaches (i.e. pharmacoepigenomics, pharmacomicrobiomics, pharmacotranscriptomics, pharmacoproteomics, pharmacometabolomics) to personalize treatment of psychiatric disorders.<\/jats:p>","DOI":"10.1017\/s0033291723002817","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T05:08:48Z","timestamp":1695964128000},"page":"7983-7993","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":67,"title":["The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review"],"prefix":"10.1017","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-8696","authenticated-orcid":false,"given":"Chad A.","family":"Bousman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7438-4551","authenticated-orcid":false,"given":"Abdullah Al","family":"Maruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo Ferri","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"S0033291723002817_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocy005"},{"key":"S0033291723002817_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2021.09.013"},{"key":"S0033291723002817_ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-5185-8"},{"key":"S0033291723002817_ref35","first-page":"29","article-title":"Pharmacogenomics testing: What the FDA says","volume":"18","author":"Ellingrod","year":"2019","journal-title":"Current Psychiatry"},{"key":"S0033291723002817_ref47","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy10060139"},{"key":"S0033291723002817_ref2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125319896650"},{"key":"S0033291723002817_ref39","unstructured":"Food & Drug Administration. (2019). Warning letter: Inova Genomics Laboratory. Retrieved April 12, 2023, from https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/inova-genomics-laboratory-577422-04042019"},{"key":"S0033291723002817_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2016.07.009"},{"key":"S0033291723002817_ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0507-5"},{"key":"S0033291723002817_ref20","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2903"},{"key":"S0033291723002817_ref30","unstructured":"CPIC. (2019). Implementation. Retrieved from https:\/\/cpicpgx.org\/implementation\/"},{"key":"S0033291723002817_ref45","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.226"},{"key":"S0033291723002817_ref59","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03891-8"},{"key":"S0033291723002817_ref18","doi-asserted-by":"publisher","DOI":"10.1177\/07067437211058847"},{"key":"S0033291723002817_ref23","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2748"},{"key":"S0033291723002817_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2019.12.001"},{"key":"S0033291723002817_ref80","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00002-0"},{"key":"S0033291723002817_ref89","doi-asserted-by":"publisher","DOI":"10.1080\/13102818.2014.933501"},{"key":"S0033291723002817_ref66","doi-asserted-by":"publisher","DOI":"10.1002\/pcn5.26"},{"key":"S0033291723002817_ref98","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.34"},{"key":"S0033291723002817_ref86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57795-0"},{"key":"S0033291723002817_ref101","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.057554"},{"key":"S0033291723002817_ref84","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxac064"},{"key":"S0033291723002817_ref102","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.229"},{"key":"S0033291723002817_ref103","first-page":"52","article-title":"Moderne problem der humangenetik","volume":"12","author":"Vogel","year":"1959","journal-title":"Ergebnisse der Inneren Medizin und Kinderheilkunde"},{"key":"S0033291723002817_ref14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/a-1288-1061","article-title":"Review and consensus on pharmacogenomic testing in psychiatry","volume":"54","author":"Bousman","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"S0033291723002817_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.10.021"},{"key":"S0033291723002817_ref21","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1409"},{"key":"S0033291723002817_ref77","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01884-3"},{"key":"S0033291723002817_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.02.143"},{"key":"S0033291723002817_ref48","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.147"},{"key":"S0033291723002817_ref75","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01340-6"},{"key":"S0033291723002817_ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.10.004"},{"key":"S0033291723002817_ref25","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocz177"},{"key":"S0033291723002817_ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.636650"},{"key":"S0033291723002817_ref82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2005.00487.x"},{"key":"S0033291723002817_ref44","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2020-0987"},{"key":"S0033291723002817_ref91","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.3"},{"key":"S0033291723002817_ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-023-01347-3"},{"key":"S0033291723002817_ref51","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31391"},{"key":"S0033291723002817_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)00017-1"},{"key":"S0033291723002817_ref58","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092890"},{"key":"S0033291723002817_ref60","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.103"},{"key":"S0033291723002817_ref12","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2022.2112949"},{"key":"S0033291723002817_ref87","first-page":"75","volume-title":"Computers and medicine","author":"Rogers","year":"1981"},{"key":"S0033291723002817_ref56","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.134"},{"key":"S0033291723002817_ref4","unstructured":"ASHP. (n.d.). Endorsed documents. Retrieved April 23, 2023, from https:\/\/www.ashp.org\/pharmacy-practice\/policy-positions-and-guidelines\/browse-by-document-type\/endorsed-documents?loginreturnUrl=SSOCheckOnly"},{"key":"S0033291723002817_ref74","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/a-0979-2322","article-title":"From the origins of pharmacogenetics to first applications in psychiatry","volume":"53","author":"M\u00fcller","year":"2020","journal-title":"Pharmacopsychiatry"},{"key":"S0033291723002817_ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s40495-019-00200-w"},{"key":"S0033291723002817_ref95","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-017-0273-2"},{"key":"S0033291723002817_ref81","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1004"},{"key":"S0033291723002817_ref99","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100507"},{"key":"S0033291723002817_ref83","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12m07807"},{"key":"S0033291723002817_ref62","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2020-0181"},{"key":"S0033291723002817_ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.02.009"},{"key":"S0033291723002817_ref53","first-page":"18","article-title":"Pharmacogenetic testing knowledge and attitudes among pediatric psychiatrists and pediatricians in Alberta, Canada","volume":"31","author":"Jessel","year":"2022","journal-title":"Journal of Canadian Academy of Child and Adolescent Psychiatry"},{"key":"S0033291723002817_ref17","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000303"},{"key":"S0033291723002817_ref41","unstructured":"Food & Drug Administration. (2023). Pharmacogenomic data submissions guidance for industry. Retrieved April 12, 2023, from https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/pharmacogenomic-data-submissions-0"},{"key":"S0033291723002817_ref42","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11121296"},{"key":"S0033291723002817_ref55","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0589-0"},{"key":"S0033291723002817_ref61","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01035-6"},{"key":"S0033291723002817_ref90","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905"},{"key":"S0033291723002817_ref94","article-title":"Child and adolescent psychiatrists\u2019 use, attitudes, and understanding of genetic tests in clinical practice","author":"Soda","year":"2023","journal-title":"medRxiv"},{"key":"S0033291723002817_ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110638"},{"key":"S0033291723002817_ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110097"},{"key":"S0033291723002817_ref67","doi-asserted-by":"publisher","DOI":"10.1177\/0706743720904820"},{"key":"S0033291723002817_ref49","article-title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update","author":"Hicks","year":"2016","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"S0033291723002817_ref37","first-page":"174","article-title":"Commercial pharmacogenetic tests in psychiatry: Do they facilitate the implementation of pharmacogenetic dosing guidelines?","volume":"53","author":"Fan","year":"2019","journal-title":"Pharmacopsychiatry"},{"key":"S0033291723002817_ref85","article-title":"Implementation of pharmacogenetics at Cincinnati children's hospital medical center: Lessons learned over 14 years of personalizing medicine","author":"Ramsey","year":"2018","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"S0033291723002817_ref26","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201500109"},{"key":"S0033291723002817_ref65","volume-title":"Convergence mental health: A transdisciplinary approach to innovation","author":"Maruf","year":"2021"},{"key":"S0033291723002817_ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108279"},{"key":"S0033291723002817_ref76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232416129"},{"key":"S0033291723002817_ref88","unstructured":"RPRD Diagnostics. (2017). Wisconsin, RPRD Diagnostics partners with St. Jude Children's Research Hospital to offer comprehensive pharmacogenetics testing. Retrieved April 12, 2023, from https:\/\/www.rprdx.com\/connect\/news\/wisconsin-rprd-diagnostics-partners-with-st-jude-childrens-research-hospital-to-offer-comprehensive-pharmacogenetics-testing\/"},{"key":"S0033291723002817_ref96","unstructured":"Statement of support for the use of European pharmacogenomic guidelines. (n.d.). Retrieved April 12, 2023, from https:\/\/upgx.eu\/wp-content\/uploads\/2018\/09\/Statement-of-support-Horizon-2020-U-PGx-final-sep-2018.pdf"},{"key":"S0033291723002817_ref104","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goac009"},{"key":"S0033291723002817_ref40","unstructured":"Food & Drug Administration. (2021). Table of pharmacogenomic biomarkers in drug labeling. Retrieved April 14, 2023, from https:\/\/www.fda.gov\/Drugs\/ScienceResearch\/ucm572698.htm"},{"key":"S0033291723002817_ref63","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.12"},{"key":"S0033291723002817_ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01269-9"},{"key":"S0033291723002817_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.08.087"},{"key":"S0033291723002817_ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13071086"},{"key":"S0033291723002817_ref38","unstructured":"Food and Drug Administration. (2020). FDA announces collaborative review of scientific evidence to support associations between genetic information and specific medications. Retrieved April 12, 2023, from https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-announces-collaborative-review-scientific-evidence-support-associations-between-genetic"},{"key":"S0033291723002817_ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.740216"},{"key":"S0033291723002817_ref28","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2354"},{"key":"S0033291723002817_ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01117-w"},{"key":"S0033291723002817_ref3","unstructured":"ASCPT. (n.d.). Tools and resources. Retrieved April 12, 2023, from https:\/\/www.ascpt.org\/Resources\/Knowledge-Center\/Tools-and-resources"},{"key":"S0033291723002817_ref34","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1237423"},{"key":"S0033291723002817_ref50","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.2"},{"key":"S0033291723002817_ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-018-0027-3"},{"key":"S0033291723002817_ref93","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2019-0799"},{"key":"S0033291723002817_ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02149-1"},{"key":"S0033291723002817_ref68","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2122"},{"key":"S0033291723002817_ref24","unstructured":"Canadian Paediatric Society. (2023). Gene-based drug therapy in children \u2013 Position Statement. Retrieved April 23, 2023, from https:\/\/cps.ca\/en\/documents\/position\/gene-based-drug-therapy-in-children"},{"key":"S0033291723002817_ref27","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0028"},{"key":"S0033291723002817_ref5","unstructured":"Assurex Health. (2016). Assurex Health to be acquired by Myriad Genetics. Retrieved April 20, 2023, from https:\/\/genesight.com\/news-and-press\/assurex-health-to-be-acquired-by-myriad-genetics-2\/"},{"key":"S0033291723002817_ref69","first-page":"258","article-title":"Favism: A brief history from the \u2018abstain from beans\u2019 of Pythagoras to the present","volume":"29","author":"Meletis","year":"2012","journal-title":"Archives of Hellenic Medicine"},{"key":"S0033291723002817_ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1922-0"},{"key":"S0033291723002817_ref92","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.114.061093"},{"key":"S0033291723002817_ref73","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1957.72980250010016"},{"key":"S0033291723002817_ref105","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01531-3"},{"key":"S0033291723002817_ref57","volume-title":"Pharmacogenetics: Heredity and the response to drugs","author":"Kalow","year":"1962"},{"key":"S0033291723002817_ref97","unstructured":"St. Catherine Specialty Hospital. (n.d.). OneOme and St. Catherine Specialty Hospital in Croatia partner to increase access to pharmacogenetic testing in Europe. Retrieved April 12, 2023, from https:\/\/www.stcatherine.com\/article\/oneome-and-st-catherine-specialty-hospital-in-croatia-partner-to-increase-access-to-pharmacogenetic-testing-in-europe\/320"},{"key":"S0033291723002817_ref64","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2019-0350"},{"key":"S0033291723002817_ref54","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2520"},{"key":"S0033291723002817_ref71","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2754"},{"key":"S0033291723002817_ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsgos.2021.07.008"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291723002817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T21:51:31Z","timestamp":1714945891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291723002817\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":106,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0033291723002817"],"URL":"https:\/\/doi.org\/10.1017\/s0033291723002817","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"assertion":[{"value":"Copyright \u00a9 The Author(s), 2023. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}